Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 11 Jul 2025

Neuropsychiatric disorders among Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder

in Multiple Sclerosis and Neuroimmunology

Edgar Patricio Correa-Díaz
Ruth Jimbo Sotomayor
Jorge Rubén Pilco Romero
Patricio Alexander Merino Aguilera

Frontiers in Neurology

doi 10.3389/fneur.2025.1587804

1,791 views
1 citation

Original Research

Published on 10 Jul 2025

Emerging epidemiological trends of multiple sclerosis among adults aged 20–54 years, 1990–2021, with projections to 2035: a systematic analysis for the global burden of disease study 2021

in Multiple Sclerosis and Neuroimmunology

Ling-yun Wang
Wen-fu Wang
Shu-yin Hui
Li Yang
Yue-xian Liu
Hang-juan Li

Frontiers in Neurology

doi 10.3389/fneur.2025.1616245

6,944 views

Original Research

Published on 07 Jul 2025

Fatigue and its correlation with anxiety and depression in patients with multiple sclerosis in China

in Multiple Sclerosis and Neuroimmunology

Han Wang
Rongrong Wang
Runze Zhao
Gaopan Zhang
Guoxun Zhang
Xiongfei Zhao

Frontiers in Neurology

doi 10.3389/fneur.2025.1604540

1,974 views

Original Research

Published on 04 Jul 2025

FCRL3 genetic variants drive autoimmune pathogenesis in multiple sclerosis and neuromyelitis optica spectrum disorders

in Multiple Sclerosis and Neuroimmunology

Hui-Fen Huang
Qi-Bing Liu
Yong-Feng Xu
Gui-Xian Zhao
Hai-Peng Liu
Hao Yu
Zhi-Ying Wu

Frontiers in Neurology

doi 10.3389/fneur.2025.1552149

2,291 views

Original Research

Published on 03 Jul 2025

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study

in Multiple Sclerosis and Neuroimmunology

Aleksandra Pogoda-Wesołowska
Adam Stępień
Marcin Wnuk
Monika Marona
Elżbieta Tokarz-Kupczyk
Karolina Piasecka-Stryczyńska
Konrad Rejdak
Anna Jamroz-Wiśniewska
Monika Adamczyk-Sowa
Katarzyna Kubicka-Bączyk

Frontiers in Neurology

doi 10.3389/fneur.2025.1626317

3,459 views
1 citation

Original Research

Published on 16 Jun 2025

Impact of visual discomfort symptoms on SDMT performance among persons with MS

in Multiple Sclerosis and Neuroimmunology

Michelle H. Chen
Timothy J. Rich
Nancy Chiaravalloti
Yael Goverover
Silvana L. Costa

Frontiers in Neurology

doi 10.3389/fneur.2025.1569451

1,603 views

Systematic Review

Published on 30 May 2025

A narrative review of the economic burden of myelin oligodendrocyte glycoprotein antibody-associated disease and analogous conditions

in Multiple Sclerosis and Neuroimmunology

Leonard Lee
Joshua Byrnes
Cathryn Hope
Hansoo Kim

Frontiers in Neurology

doi 10.3389/fneur.2025.1506465

2,939 views
1 citation

Original Research

Published on 29 May 2025

Progression independent of relapsing biology in multiple sclerosis: a real-word study

in Multiple Sclerosis and Neuroimmunology

Heather Y. F. Yong
Carlos Camara-Lemarroy

Frontiers in Neurology

doi 10.3389/fneur.2025.1595929

2,950 views
1 citation

Original Research

Published on 21 May 2025

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

in Multiple Sclerosis and Neuroimmunology

Mathias Buttmann
Martin S. Weber
Sven G. Meuth
Sandra Blümich
Stefanie Hieke-Schulz
Petra Dirks
Julius C. Eggebrecht
Tjalf Ziemssen

Frontiers in Neurology

doi 10.3389/fneur.2025.1564327

4,104 views
1 citation

Original Research

Published on 21 May 2025

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

in Multiple Sclerosis and Neuroimmunology

Tyler L. Borko
Phillip Winters
Kelli M. Money
Stefan Sillau
Sadie Eggmann
Sean Selva
Alanna Ritchie
Ryan Kammeyer
Gregory P. Owens
Jeffrey L. Bennett

Frontiers in Neurology

doi 10.3389/fneur.2025.1583892

2,854 views

Original Research

Published on 21 May 2025

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

in Multiple Sclerosis and Neuroimmunology

Qiqi Peng
Xiaoping Yao
Sheng Chen
Xiaofeng Li
Feifei Lin
Zhangyu Zou

Frontiers in Neurology

doi 10.3389/fneur.2025.1560483

2,904 views
4 citations

Study Protocol

Published on 16 May 2025

RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Jelle Praet
Lina Anderhalten
Giancarlo Comi
Dana Horakova
Tjalf Ziemssen
Patrick Vermersch
Carsten Lukas
Koen Van Leemput
Marjan Steppe
Noemí Manero

Frontiers in Neurology

doi 10.3389/fneur.2025.1557947

2,941 views

Clinical Trial

Published on 09 May 2025

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

in Multiple Sclerosis and Neuroimmunology

Mahsa Hosseini
Soheila Shamsikhani
Ali Jadidi
Fatemeh Rafiei

Frontiers in Neurology

doi 10.3389/fneur.2025.1521112

2,246 views

Original Research

Published on 09 May 2025

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

in Multiple Sclerosis and Neuroimmunology

Shan Qiao
Jia Wang
Shan-chao Zhang
Ai-hua Wang
Hai-yun Li
Tao Xin

Frontiers in Neurology

doi 10.3389/fneur.2025.1568274

2,323 views

Correction

Published on 08 May 2025

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

in Multiple Sclerosis and Neuroimmunology

Domenico A. Restivo
Angelo Quartarone
Antongiulio Bruschetta
Angelo Alito
Demetrio Milardi
Rosario Marchese-Ragona
Ennio Iezzi
Sheila Peter
Diego Centonze
Mario Stampanoni Bassi

Frontiers in Neurology

doi 10.3389/fneur.2025.1613012

1,725 views

Original Research

Published on 07 May 2025

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

in Multiple Sclerosis and Neuroimmunology

Mohammadali Arami
Rezafarhad Manteghifasaei
Mohammad Karimi
Puya Zandi
Mobina Javadi

Frontiers in Neurology

doi 10.3389/fneur.2025.1565912

3,143 views

Original Research

Published on 30 Apr 2025

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Eman M. Khedr
Gellan K. Ahmed
Shady Safwat Hassan
Mohamed Nageh Foly
Motez Mahmoud Attia
Ahmed A. Karim
Nourelhoda A. Haridy

Frontiers in Neurology

doi 10.3389/fneur.2025.1563041

2,389 views
1 citation

Original Research

Published on 29 Apr 2025

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

in Multiple Sclerosis and Neuroimmunology

Miguel Ángel Robles-Sánchez
Paloma Amil-Bujan
Cristina Bosch-Farré
Clàudia Coll-Martínez
María Jesús Arévalo
Elisenda Anglada-Clofent
Rebeca Menéndez-Díaz
Montserrat Aroca-Alsina
Miguel Merchan-Ruiz
Santiago Pérez-Hoyos

Frontiers in Neurology

doi 10.3389/fneur.2025.1581038

2,856 views

Original Research

Published on 28 Apr 2025

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

in Multiple Sclerosis and Neuroimmunology

Jing Zhou
Xiaolin Yang
Xinyi Wang
Bin Li
Yun Xu
Haoran Zhang
Yinxin Zhu
Xiaoming Wang
Jinzhou Feng

Frontiers in Neurology

doi 10.3389/fneur.2025.1559118

4,521 views
3 citations

Original Research

Published on 28 Apr 2025

Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod

in Multiple Sclerosis and Neuroimmunology

Min Chen
Zhuajin Bi
Wenzhong Kang
Ruihan Liu
Liu Hongbo
Yan Jiang
Qun Wang

Frontiers in Neurology

doi 10.3389/fneur.2025.1550023

3,120 views

Original Research

Published on 16 Apr 2025

Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics

in Multiple Sclerosis and Neuroimmunology

Anna Neupokoeva
Ivan Bratchenko
Lyudmila Bratchenko
Elena Khivintseva
Igor Shirolapov
Natalia Shusharina
Matvei Khoimov
Valery Zakharov
Alexander Zakharov

Frontiers in Neurology

doi 10.3389/fneur.2025.1516712

1,955 views
1 citation

Original Research

Published on 15 Apr 2025

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

in Multiple Sclerosis and Neuroimmunology

Ann-Sophie Stratil
Steffeni Papukchieva
Nils-Henning Neß
Inge Wolf
Antonios Bayas
Peter Flachenecker
Benjamin Friedrich

Frontiers in Neurology

doi 10.3389/fneur.2025.1561810

2,465 views

Case Report

Published on 10 Apr 2025

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

in Multiple Sclerosis and Neuroimmunology

Rui-Ting Liu
Yu-Kun Guo
Xia Du
Heng Li

Frontiers in Neurology

doi 10.3389/fneur.2025.1559872

3,639 views
1 citation

Editorial

Published on 03 Apr 2025

Editorial: Spatial transcriptome and single-cell sequencing for exploring molecular mechanisms of neuroimmunity and discovering novel markers of neurological diseases

in Multiple Sclerosis and Neuroimmunology

Bowen Wang
Yachen Shi
Chao Cheng
Jian Song
Yuanbo Pan

Frontiers in Neurology

doi 10.3389/fneur.2025.1582019

1,769 views

1,177 articles

articles

Neuropsychiatric disorders among Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder

Emerging epidemiological trends of multiple sclerosis among adults aged 20–54 years, 1990–2021, with projections to 2035: a systematic analysis for the global burden of disease study 2021

Fatigue and its correlation with anxiety and depression in patients with multiple sclerosis in China

FCRL3 genetic variants drive autoimmune pathogenesis in multiple sclerosis and neuromyelitis optica spectrum disorders

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study

Impact of visual discomfort symptoms on SDMT performance among persons with MS

A narrative review of the economic burden of myelin oligodendrocyte glycoprotein antibody-associated disease and analogous conditions

Progression independent of relapsing biology in multiple sclerosis: a real-word study

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod

Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

Editorial: Spatial transcriptome and single-cell sequencing for exploring molecular mechanisms of neuroimmunity and discovering novel markers of neurological diseases

articles

Neuropsychiatric disorders among Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder

Emerging epidemiological trends of multiple sclerosis among adults aged 20–54 years, 1990–2021, with projections to 2035: a systematic analysis for the global burden of disease study 2021

Fatigue and its correlation with anxiety and depression in patients with multiple sclerosis in China

FCRL3 genetic variants drive autoimmune pathogenesis in multiple sclerosis and neuromyelitis optica spectrum disorders

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study

Impact of visual discomfort symptoms on SDMT performance among persons with MS

A narrative review of the economic burden of myelin oligodendrocyte glycoprotein antibody-associated disease and analogous conditions

Progression independent of relapsing biology in multiple sclerosis: a real-word study

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod

Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

Editorial: Spatial transcriptome and single-cell sequencing for exploring molecular mechanisms of neuroimmunity and discovering novel markers of neurological diseases

Emerging epidemiological trends of multiple sclerosis among adults aged 20–54 years, 1990–2021, with projections to 2035: a systematic analysis for the global burden of disease study 2021